Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-300
Closed -$29K 7955
2016
Q2
$29K Buy
+300
New +$28.2K ﹤0.01% 5965
2015
Q4
Sell
-542
Closed -$56K 8601
2015
Q3
$56K Buy
542
+538
+13,450% +$67.2K ﹤0.01% 5737
2015
Q2
$1K Hold
4
﹤0.01% 8336
2015
Q1
$1K Sell
4
-76
-95% -$8.97K ﹤0.01% 8597
2014
Q4
$8K Buy
+80
New +$10.9K ﹤0.01% 8613

Other funds holding VEON

UBS Group's VEON Position: Q1 2026 in Review

UBS Group increased its VEON (VEON) stake by 79% in Q1 2026, buying an estimated $399K and bringing the position to 17,217 shares worth $797K. The position accounts for ﹤0.01% of the portfolio, ranked #5727.

UBS Group first reported a position in VEON in Q4 2014 and has held it in 46 quarters since. The position peaked at $10.6M in Q1 2021. 101 funds tracked by Wall St. Rank hold VEON as of Q1 2026.

  • UBS Group held 17,217 shares of VEON worth $797K as of Q1 2026.
  • UBS Group bought 7,582 VEON shares in Q1 2026, an estimated $399K.
  • VEON made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5727 holding.
  • UBS Group first reported a position in VEON in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's VEON position peaked at $10.6M in Q1 2021.
  • 101 funds tracked by Wall St. Rank held VEON as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.